SECsense Logo

Moleculin Biotech, Inc. 8-K Report: Key Updates Revealed on January 8, 2025

$MBRX
Form 8-K
Filed on: 2025-01-08
Source
Moleculin Biotech, Inc. 8-K Report: Key Updates Revealed on January 8, 2025

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Name: Moleculin Biotech, Inc.
  • CIK: 0001659617
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-37758
  • EIN: 47-4671997
  • Address: 5300 Memorial Drive, Suite 950, Houston, TX 77007
  • Phone Number: 713-300-5160
  1. Filing Information:
  • Filing Type: 8-K
  • Filing Date: January 8, 2025
  • Period Covered: January 8, 2025 (the report appears to be for a single day)
  1. Securities Information:
  • Type of Security: Common Stock
  • Ticker Symbol: MBRX
  • Exchange: NASDAQ
  1. XML/XBRL Context:
  • The report is structured in XBRL format, which is designed for electronic filing and data extraction.
  • The report references a schema file (mbrx-20250108.xsd), indicating it follows a specific data model.

Insights:

  • The filing is an 8-K, which typically reports unscheduled material events or corporate changes that are of importance to shareholders. This suggests that there may be significant news or updates regarding Moleculin Biotech, Inc. on this date.
  • The report is structured for compliance with SEC regulations, ensuring that the data provided is accessible and verifiable.
  • The inclusion of standard identifiers like CIK and EIN indicates the firm’s established presence in the public market and compliance with regulatory requirements.

Overall, this section indicates that Moleculin Biotech may be making an important announcement or change that warrants an 8-K filing on January 8, 2025.